Stanford Adult Cystic
Fibrosis Patient Advisory Council
Date/Time: Wednesday, September 17, 5:00pm-6:15pm
Location: Blake Wilbur Room W1084
& Join Webex
WebEx
members should get set up 10 minutes before the scheduled meeting time using
the link provided in the green button on the WebEx dialog below or the link at
the bottom of the form. It is
recommended you call in for audio as opposed to using your computer.
Advisory
Council visitors are welcome. Attendees
must respect the Stanford CF Center cross infection guidelines, which at this
time allow only one individual with CF in the meeting room. This week that person will be Angel. Please do not attend in person if you have an
active viral infection or any other contagious condition.
Please have this copy of the agenda and attachments with
you during the meeting.
Agenda
1.
Introduction (5:00 – 5:10)
a. Welcome
Annette and Shawn!
2.
Adopt August minutes (5:10)
a. Please
review Angel’s minutes on the blog or via her email previously sent to you
3.
Candidates for Vice-Chair (5:10 – 5:20)
4.
Infection Control Policy – Colleen (5:20 – 5:30)
5.
Council Time Commitment Concerns – Discussion (5:30 – 5:40)
6.
Ideas on Improving our Visibility and Increasing Membership
(5:40 – 5:45)
7.
CF PAC Project Update – (5:45 – 6:00)
a. Virtual
Meeting Proposal/Online Collaboration – Brian E.
i. CFF
Collaboration – Coordination with CFF and external clinic development
ii. Stanford
(internal) – no update
iii. MyHealth
project status – no update
b. Clinic-Patient
Opportunities – Monica/Angel/Elika
i. List
Definition – Status
ii. Ongoing
Tracking
c. Collaboration
with other advisory boards
i. Angel/Ann
report out
ii. Patient
Family Partner Board report out – Brian E.
1. Initial
Meeting (7/31/14)
2. Eighth
Annual Summit for Clinical Excellence – November
iii. NACFC
contact – Brian E.
8.
Action Items from Previous Meeting (6:00 – 6:10)
a. Angel – Contact
Jennifer to see if the MyHealth team has been in contact with her regarding
email issues
b. Jay –
Contact Camille, Elika or Meg regarding updates on Patient Questioner Form
c. Joan
– investigate "parking cheats" for unique cases
9.
Proposals for New Projects (6:10 – 6:15)
a. Pending
Future Project: Joan and Brian E to contact Christine from MyHealth to see about a possible collaboration between Epic
Synopsis and MyHealth
Adjournment - Next meeting 10/15/14
|
|
Administrator Administrator invites you to this meeting.
|
|
|
|
|
CF Meeting 9/17/2014 5:00PM-6:15
|
|
|
Wed, Sep 17, 5:00 PM
|
(UTC-08:00) Pacific Time (US
& Canada)
|
|
|
|
This invite is for the CF
MEETING
• Telepresence attendees please press the join button on your touch
screen to connect.
• WebEx attendees please click the green "Join Using WebEx' tab
within this invite.
• Next join the WebEx audio bridge by phone. Do not use computer
audio.
• WebEx attendees to enable your laptop camera click the camera icon
next to your name in the meeting participants list.
Questions call:
Tom Metz
Unified Communications
650 492 3675
|
|
|
|
|
|
|
Meeting password: 2013
|
Meeting number: 346312029
|
|
|
|
|
|
Join Using Telepresence
|
|
|
|
Video address:
|
|
|
7527501@stanfordmed.org
|
|
|
Locations:
|
|
|
TP-900 Blake Wilbur-Tumor
Board W1084
|
|
|
|
|
|
|
Audio Connection
|
|
|
|
Call-in numbers
|
|
|
Toll: +1-415-655-0000
|
Toll-free: 1-877-668-4488
|
|
|
Access code: 346312029
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
If you need the host key or cannot
join the meeting using WebEx from this email message, go here:
|
|
|
Need more details about joining the
meeting using telepresence?
|
|
|
Having trouble joining from a
telepresence room? Get help.
|
|
IMPORTANT NOTICE: This WebEx
service includes a feature that allows audio and any documents and other
materials exchanged or viewed during the session to be recorded. By
joining this session, you automatically consent to such recordings. If
you do not consent to the recording, discuss your concerns with the
meeting host prior to the start of the recording or do not join the
session. Please note that any such recordings may be subject to discovery
in the event of litigation.
|
|
|
No comments:
Post a Comment